Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Insulin Lispro Mix 25 vs Humalog Mix 25 in Healthy Subjects
NCT03606018Phase 1Completed
- Sponsor
- Geropharm
- Start
- Apr 2017
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro mix25 in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Maximum Plasma Concentration and Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration. Started Apr 2017; status: completed.
02
Drugs
insulin lispro mix25
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03606018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606018.